SCHEMBL5656739

SCHEMBL5656739

COc1ccc2nccc(C(O)CN3CCC(N)C(F)C3)c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 8/20 0.55
KCNH2 Q12809 3/20 0.55
CYP2D6 P10635 5/20 0.49
ALDH1A1 P00352 5/20 0.49
HSD17B10 Q99714 5/20 0.49
KDM4E B2RXH2 4/20 0.49
HPGD P15428 3/20 0.49
CYP3A4 P08684 3/20 0.49
TSHR P16473 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ADRA2A P08913 2/20 0.49
SLC6A4 P31645 2/20 0.49
OPRM1 P35372 2/20 0.49
SLC6A3 Q01959 2/20 0.49
CHRM2 P08172 1/20 0.49
THRB P10828 1/20 0.47
SLC22A1 O15245 1/20 0.47
ABCC4 O15439 1/20 0.47
CACNA1F O60840 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5656743 1.00 SLC2A1 (0.55) SLC2A1KCNH2CYP2D6ALDH1A1HSD17B10
SCHEMBL3247972 1.00 SLC2A1 (0.55) SLC2A1KCNH2CYP2D6ALDH1A1HSD17B10
SCHEMBL5657534 1.00 SLC2A1 (0.55) SLC2A1KCNH2CYP2D6ALDH1A1HSD17B10
SCHEMBL5657314 1.00 SLC2A1 (0.55) SLC2A1KCNH2CYP2D6ALDH1A1HSD17B10
SCHEMBL3247971 1.00 SLC2A1 (0.55) SLC2A1KCNH2CYP2D6ALDH1A1HSD17B10
SCHEMBL5256396 0.88 SLC2A1 (0.63) SLC2A1KCNH2CYP2D6ALDH1A1HSD17B10
SCHEMBL5256391 0.88 SLC2A1 (0.63) SLC2A1KCNH2CYP2D6ALDH1A1HSD17B10
SCHEMBL4269291 0.88 SLC2A1 (0.63) SLC2A1KCNH2CYP2D6ALDH1A1HSD17B10
SCHEMBL13356539 0.88 CYP2D6 (0.56) SLC2A1KCNH2CYP2D6ALDH1A1HSD17B10
Hydrochloric Acid SCHEMBL5411589 0.87 SLC2A1 (0.62) SLC2A1KCNH2CYP2D6ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312212-B2 Aminopiperidine derivatives GLAXO GROUP LIMITED (GB) 2007-12-25 US disclosed
US-20050159411-A1 Aminopiperidine derivatives GLAXO GROUP LIMITED (GB) 2005-07-21 US disclosed
EP-1470125-A1 AMINOPIPERIDINE DERIVATIVES GLAXO GROUP LIMITED (GB) 2004-10-27 EP disclosed
WO-2003064421-A1 AMINOPIPERIDINE DERIVATIVES GLAXO GROUP LIMITED (GB) 2003-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050159411-A1 Aminopiperidine derivatives AMPD2, AMPD3, NPEPPS SLC2A1 3708/4885KCNH2 1182/4885CYP2D6 850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.